Abstract

In patients with recent stroke or TIA and without known coronary heart disease, 80 mg of atorvastatin per day reduced the overall incidence of strokes and of cardiovascular events, despite a small increase in the incidence of hemorrhagic stroke. (ClinicalTrials.gov number, NCT00147602 [ClinicalTrials.gov].).

Keywords

MedicineAtorvastatinHazard ratioStroke (engine)PlaceboConfidence intervalInternal medicineLiterClinical endpointCardiologyGastroenterologySurgeryRandomized controlled trial

Affiliated Institutions

Related Publications

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever , Björn Dahlöf , Neil R Poulter +11 more

The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol loweri...

2003 The Lancet 3773 citations

Publication Info

Year
2006
Type
article
Volume
355
Issue
6
Pages
549-559
Citations
2823
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2823
OpenAlex

Cite This

Pierre Amarenco, Julien Bogousslavsky, Alfred Callahan et al. (2006). High-Dose Atorvastatin after Stroke or Transient Ischemic Attack. New England Journal of Medicine , 355 (6) , 549-559. https://doi.org/10.1056/nejmoa061894

Identifiers

DOI
10.1056/nejmoa061894